Home > News > From Flameout to Bargain
July 8th, 2004
From Flameout to Bargain
The stock of biopharmaceutical and Merrill Lynch (NYSE: MER) Nanotech Index (AMEX: NNZ) member Flamel Technologies (Nasdaq: FLML) has declined more than 50% since hitting a $43.60 all-time high in September. The stock, down 11% today on no discernible news, is not matching the 20% increase, since May, of its index peers. Although the recent stock flameout might be an indication of trouble, a closer look reveals a lot to like.
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 4, 2014 January 15th, 2014
Nanobiotix 2013 Review: Significant Corporate and Clinical Progress January 7th, 2014